Literature DB >> 27085899

Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid.

Daniel H Hwang1, Jeong-A Kim2, Joo Young Lee3.   

Abstract

Saturated fatty acids can activate Toll-like receptor 2 (TLR2) and TLR4 but polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA) inhibit the activation. Lipopolysaccharides (LPS) and lipopetides, ligands for TLR4 and TLR2, respectively, are acylated by saturated fatty acids. Removal of these fatty acids results in loss of their ligand activity suggesting that the saturated fatty acyl moieties are required for the receptor activation. X-ray crystallographic studies revealed that these saturated fatty acyl groups of the ligands directly occupy hydrophobic lipid binding domains of the receptors (or co-receptor) and induce the dimerization which is prerequisite for the receptor activation. Saturated fatty acids also induce the dimerization and translocation of TLR4 and TLR2 into lipid rafts in plasma membrane and this process is inhibited by DHA. Whether saturated fatty acids induce the dimerization of the receptors by interacting with these lipid binding domains is not known. Many experimental results suggest that saturated fatty acids promote the formation of lipid rafts and recruitment of TLRs into lipid rafts leading to ligand independent dimerization of the receptors. Such a mode of ligand independent receptor activation defies the conventional concept of ligand induced receptor activation; however, this may enable diverse non-microbial molecules with endogenous and dietary origins to modulate TLR-mediated immune responses. Emerging experimental evidence reveals that TLRs play a key role in bridging diet-induced endocrine and metabolic changes to immune responses. Published by Elsevier B.V.

Entities:  

Keywords:  Docosahexaenoic acid; Docosahexaenoic acid (PubChem CID: 445580); Inflammation; Lipopolysaccharide core (CID: 53481794); Palmitic acid (PubChem CID: 985); Pam(3)Csk(4) (CID: 130704); Polyunsaturated fatty acid; Saturated fatty acid; Toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 27085899      PMCID: PMC5815395          DOI: 10.1016/j.ejphar.2016.04.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  63 in total

1.  Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

Authors:  J Y Lee; K H Sohn; S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2001-03-02       Impact factor: 5.157

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Exploring the LPS/TLR4 signal pathway with small molecules.

Authors:  Francesco Peri; Matteo Piazza; Valentina Calabrese; Gaetana Damore; Roberto Cighetti
Journal:  Biochem Soc Trans       Date:  2010-10       Impact factor: 5.407

4.  Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase.

Authors:  S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

5.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

6.  Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.

Authors:  Ryan G Snodgrass; Shurong Huang; Il-Whan Choi; John C Rutledge; Daniel H Hwang
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids.

Authors:  Joo Y Lee; Anthony Plakidas; Won H Lee; Anne Heikkinen; Prithiva Chanmugam; George Bray; Daniel H Hwang
Journal:  J Lipid Res       Date:  2002-12-01       Impact factor: 5.922

Review 9.  Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids.

Authors:  Joo Y Lee; Ling Zhao; Daniel H Hwang
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

10.  Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages.

Authors:  Jeb S Orr; Michael J Puglisi; Kate L J Ellacott; Carey N Lumeng; David H Wasserman; Alyssa H Hasty
Journal:  Diabetes       Date:  2012-06-29       Impact factor: 9.461

View more
  63 in total

1.  The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.

Authors:  Misaki Matsumoto; Jia Zhang; Xueqing Zhang; Junjie Liu; Joy X Jiang; Kanji Yamaguchi; Akiyuki Taruno; Masato Katsuyama; Kazumi Iwata; Masakazu Ibi; Wenhao Cui; Kuniharu Matsuno; Yoshinori Marunaka; Yoshito Itoh; Natalie J Torok; Chihiro Yabe-Nishimura
Journal:  Free Radic Biol Med       Date:  2017-12-20       Impact factor: 7.376

2.  Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ, LP(a), IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease.

Authors:  Ali Akbar Hashemzadeh; Nikoo Nasoohi; Fariba Raygan; Esmat Aghadavod; Elmira Akbari; Mohsen Taghizadeh; Mohammad Reza Memarzadeh; Zatollah Asemi
Journal:  Lipids       Date:  2017-09-15       Impact factor: 1.880

Review 3.  Nutrigenomics of Dietary Lipids.

Authors:  Laura Bordoni; Irene Petracci; Fanrui Zhao; Weihong Min; Elisa Pierella; Taís Silveira Assmann; J Alfredo Martinez; Rosita Gabbianelli
Journal:  Antioxidants (Basel)       Date:  2021-06-22

4.  Bifidobacterium pseudocatenulatum CECT 7765 Ameliorates Neuroendocrine Alterations Associated with an Exaggerated Stress Response and Anhedonia in Obese Mice.

Authors:  Ana Agusti; A Moya-Pérez; I Campillo; S Montserrat-de la Paz; V Cerrudo; A Perez-Villalba; Yolanda Sanz
Journal:  Mol Neurobiol       Date:  2017-09-18       Impact factor: 5.590

5.  A Western-type dietary pattern and atorvastatin induce epicardial adipose tissue interferon signaling in the Ossabaw pig.

Authors:  Maura E Walker; Nirupa R Matthan; Gloria Solano-Aguilar; Saebyeol Jang; Sukla Lakshman; Aleksey Molokin; Tyler Faits; Joseph F Urban; W Evan Johnson; Stefania Lamon-Fava; Alice H Lichtenstein
Journal:  J Nutr Biochem       Date:  2019-02-20       Impact factor: 6.048

Review 6.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

7.  Conjugation inhibitors compete with palmitic acid for binding to the conjugative traffic ATPase TrwD, providing a mechanism to inhibit bacterial conjugation.

Authors:  Yolanda García-Cazorla; María Getino; David J Sanabria-Ríos; Néstor M Carballeira; Fernando de la Cruz; Ignacio Arechaga; Elena Cabezón
Journal:  J Biol Chem       Date:  2018-09-10       Impact factor: 5.157

Review 8.  The Influence of Obesity and Associated Fatty Acids on Placental Inflammation.

Authors:  Alison J Eastman; Rebecca E Moore; Steven D Townsend; Jennifer A Gaddy; David M Aronoff
Journal:  Clin Ther       Date:  2021-01-21       Impact factor: 3.393

9.  The Pros and Cons of Low Carbohydrate and Ketogenic Diets in the Prevention and Treatment of Cancer.

Authors:  Ingrid Elisia; Gerald Krystal
Journal:  Front Nutr       Date:  2021-02-25

10.  Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size.

Authors:  Claudio Maldonado; Mai-Dung Nguyen; Phillip Bauer; Shunichi Nakamura; Syed J Khundmiri; Gustavo Perez-Abadia; Heather L Stowers; Wen-Jian Wu; Xian-Liang Tang
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-20       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.